With Major News In 2021 And Strong Analyst Coverage, This Nasdaq Profile Could Be Ready To Erupt
New Report Arrives 9:30AM EST Wednesday
Sign Up To My SMS Update System - Directions Below
The market is open at the moment, so I don't want to take too much of your time.
I've got a new Nasdaq profile coming your way and you'll need to have your schedule cleared in preparation.
Tomorrow at 9:30AM EST, the complete report arrives. Here's what you need to know ahead of time.
According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally.
In fact, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths.
Of these deaths, 85% were due to heart attack and stroke.
Cardiovascular devices are medical devices designed for monitoring, preventing, diagnosing, and treating diseases associated with the cardiovascular system or heart related diseases.
The market for these devices was valued at $40.8Bn in 2018 and it is projected to reach $71.1Bn in 2027; it is expected to grow at a CAGR of 6.5% from 2019 to 2027.
And, one company's game-changing first product could impact this market greatly as it aims to provide physicians with a better idea of heart related issues.
Trust me. You will not want to miss this report.
To give you a taste of what's coming, here's a couple potential catalysts that could spark this profile towards a possible breakout.
Your Top 3 Potential Catalysts For This Nasdaq Idea
#1. Multiple analysts are providing price targets that give this profile over 100% potential upside from Monday's closing st-ock price valuation.
#2. As of close on Monday, this profile was trading above several lines of potential support and could be eying a possible squeeze if it can push through its 200-Day Simple Moving Average.
#3. News, news, and more news. This company has not been shy about corporate doings and upcoming events. Could this company's next big update provide breakout fuel in the near term?
While you've got some time now, do this: